estimates that approximately 520,000-840,000 postpartum women or women with heavy uterine bleeding would be candidates for this product.
There are many important factors that could cause actual results to differ materially from those indicated in the forward-looking statements, including that: (i) the FDA may not be satisfied with the Company's amendment to its PMA and may determine such PMA is not approvable or require additional clinical trials; (ii) despite the Company's future marketing and commercialization efforts, Augment and Augmatrix may not achieve broad market acceptance; and (iii) Luitpold
may not make a milestone payment to the Company for EU approval of the CE Mark for GEM 21S whether or not the EU regulatory authorities determine that such CE Mark was properly granted or approve such CE Mark for Augment as a medical device.
estimates that about 520,000-840,000 postpartum women or women with heavy uterine bleeding would be candidates for the product.
Pharmaceuticals, 2005; MIRoTEC Australia 2002; Progressive Nutrition, 2003 (all Jerry Duff); Agri Laboratories, 2002; America's Alfalfa, 2000; Felton International, 2002; Hytest Seeds, 2000 (all Mary Jane Duff)
He is HRH Prinz Luitpold
yon Bayern, also the great-grandson of the last King of Bavaria, Ludwig II, a member of the royal family of Bavaria, the Wittelsbachs, who have brewed beer for seven centuries.
Frommel and Matthias Winner, 237-43.
NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that Luitpold
Pharmaceuticals, a pioneer in the development and marketing of a wide variety of drugs and medical devices, will use BioClinica's Express Electronic Data Capture ("EDC") system for multiple upcoming clinical trials.
In this context, The bridge caps at the luitpold
bridge are to be widened by approx.
M2 PHARMA-October 13, 2011-Daiichi Sankyo's Luitpold
seeks FDA nod for IV iron replacement therapy Injectafer(C)2011 M2 COMMUNICATIONS
Ad ag accts: Exosect Limited (Exosex[TM]) (projects), 2004; Heska Corporation (Heska Lab Systems), 2003; Luitpold
Pharmaceuticals (Adequan[R]), 2003; Schering-Plough Animal Health (ProTICall), 1998; STAR Horse Products (Freedom[R] for Horses), 2004 (all Dean LePoidevin)
of Bavaria said publicly last week that the price of 12 marks ($5.
Pharmaceuticals, a subsidiary of Daiichi Sankyo, Inc.